Natriuretic Peptide Is Strong Predictor of Mortality
15th Feb 2006, 04:09 GMT
BOSTON - Not only can natriuretic peptide testing help diagnose heart failure in emergency room patients with shortness of breath, the test is also a strong predictor of these patients' mortality risk one year later, researchers here reported.
Natriuretic Peptide Is Strong Predictor of Mortality related news:
- Metabolic Acidosis Predicts Mortality In ICU Patients — MedPage Today.com Latest Headlines
- Predicting the risk of death in patients with known coronary artery disease — KeralaNext: Latest News
- Viewpoint: Reductions in Hispanic and non-Hispanic Asthma Mortality — Medscape Headlines
- Blood Test Predicts Mortality Risk in Coronary Disease — MedPage Today Cardiovascular
- Study: US Hospitals Rated In Top 5 Percent Have Mortality Rates 27 Percent Lower — Medical News Today RSS/XML Feed
- Metabolic acidosis associated with an increased mortality rate — EurekAlert! - Breaking News
- State says 2004 infant mortality rate lowest on record — WOODTV - News - Local
- FCCL maker Taiflex Scientific expects strong 1H — DigiTimes: IT news from Asia
- Strong, Tobeck Among 1st Time Pro Bowlers — www.heraldsun.com
- Seahawks veterans Strong, Tobeck among first-time Pro Bowlers — PittsburghLIVE.com
Latest news from MedPage Today Cardiovascular:
- AHA: Women Receive Less Cardiovascular Secondary Prevention
- AHA: Chest Protectors Have Fatal Flaws in Blocking Cardiac Arrest
- AHA: No Cardiovascular Benefit from Folic Acid and B Vitamins
- AHA: Attention from Pharmacist Improves Compliance for Older Patients
- AHA: Non-Invasive Office-Based Test Could Increase Appropriate Use of ICDs
- AHA: Human Atrial Natiuretic Peptide May Reduce Reperfusion Injury
- AHA: Blood Test Improves Management of Acute Heart Failure
- AHA: Novel Drug Effective for Hyponatremia in Heart Failure Patients